101) y in which the father suffers from celiac disease and Hashimoto's disease, his daugh |
102) r typical proteinopathies are Alzheimer's disease and Parkinson's disease. |
103) s function, low Norton scale, Parkinson's disease and anaemia due to chronic disease |
104) tion in the management of metastatic bone disease and bone loss/osteoporosis in wome |
105) es were allergies, asthma, diabetes, lung disease and cardiovascular disease. |
106) Coronary artery disease and cerebral stroke represent the |
107) isease, stroke, cancer, and chronic liver disease and cirrhosis were significant ris |
108) ey disease, cancer, stroke, chronic liver disease and cirrhosis, or diabetes had a h |
109) cy of MSCs in cases of inflammatory bowel disease and degenerative conditions of the |
110) gh SMRs of more than 20 for hematological disease and digestive system disease. |
111) from large animal models of Huntington's disease and discusses the use of large ani |
112) ds describing the data, understanding the disease and drug action over time, investi |
113) r students had little knowledge about the disease and how to handle it. |
114) further exacerbate heat-related burden of disease and loss of productivity in many j |
115) Patients with congenital heart disease and matched healthy controls were |
116) join with a very limited understanding of disease and medical research and where an |
117) Patients with coeliac disease and myocardial infarction have a m |
118) In multivariate analyses, advanced stage disease and negative hormone receptor stat |
119) of dysregulated polysialylation for brain disease and neuropsychiatric disorders are |
120) ribed genetic risk factor for Alzheimer's disease and nonpathological cognitive decl |
121) neum that typically present with advanced disease and often carry a poor prognosis. |
122) not improve long-term outcomes of Crohn's disease and places patients at risk for bo |
123) ays and means to alleviate the spectre of disease and poverty from the endemic areas |
124) HFrEF), i.e., those with structural heart disease and previous or current symptoms. |
125) of secondary data from the participatory disease and response (PDSR) database revea |
126) clude tumour size, presence of metastatic disease and serum alkaline phosphatase (AL |
127) applied to describing the progression of disease and the action of drugs to change |
128) the absence of history of cardiovascular disease and the chronology of this complic |
129) lected related to the epidemiology of the disease and the numbers of affected cattle |
130) eumatoid arthritis and inflammatory bowel disease and the study of the atheroma plaq |
131) stem-cell transplantation, had refractory disease and then had achieved long-term re |
132) d BMD and various demographic, lifestyle, disease and therapy variables in patients |
133) te was present in only 3 patients with SS disease and was absent in the controls. |
|